Skip to Main Content

20-850 Learn What Services Will Now Require a Prior Authorization Request

Date: 10/27/20

This information applies to Physicians, Participating Physician Groups (PPGs), Hospitals, and Ancillary providers.

For Medi-Cal, this information applies to Kern, Los Angeles, Riverside, Sacramento, San Bernardino, San Diego, San Joaquin, Stanislaus, and Tulare counties.

Prior authorization request changes start  January 1, 2021

Please review the prior authorization (PA) requirement changes listed below.

Medications requiring PA effective immediately

The below medications require PA immediately for all products per new injectable medication HCPCS codes issued by the Centers for Medicare & Medicaid Services on October 1, 2020:

  • Durysta
  • Istodax®
  • Jelmyto
  • Monoferric®
  • Pemfexy
  • Sarclisa®
  • Tepezza®
  • Trodelvy
  • Vyepti
  • Zulresso

View PA requirements online

You can access current PA requirements and directions to submit requests using the directions below.

If you are servicing a member enrolled in…

Access prior authorization requirements with these steps

  • Employer group HMO, PPO, EPO
  • Point of Service (POS)
  • Medi-Cal

1    Go to the Health Net provider portal.

2    Pre-log in, select Working with
Health Net > Policies for Non-Contracting Providers > Additional Resources > Services Requiring Prior Authorization
.

3    Post-log in, select Working with
Health Net > Contractual > Services Requiring Prior Authorization
.

  • IFP CommunityCare HMO
  • IFP PureCare HSP
  • PPO Individual and Family
  • IFP EnhancedCare PPO
  • IFP PureCare One EPO

1     Go to  the IFP provider portal, select For Providers > Working with Health Net.

2     Under Additional Resources, select Services Requiring Prior Authorization.

3     Select the product under Online Prior Authorization Validation Tools.

4     If the code requires prior authorization, log in to the Health Net provider portal to submit an authorization request.

If you have questions regarding the information contained in this update, contact the applicable Health Net Provider Services Center within 60 days as listed below.

Medi-Cal fee-for-service

The below PA requirement changes are for Health Net’s Medi-Cal fee-for-service providers. “New” indicates new requirement, “Existing” indicates current requirement and “N/A” indicates not applicable.

 

Additions, effective January 1, 2021
RequirementCommentsAdult members ages 21 and overPediatric members under age 21

Biosimilars

Biosimilars are required to be used in lieu of branded drugs.

New

New

Remodulin®, Ruconest®

Listed under Outpatient Pharmaceuticals (Submitted under Medical Plan).

New

New

 

Changes, effective January 1, 2021
RequirementCommentsAdult members ages 21 and overPediatric members under age 21

Rehabilitation services

Includes physical, occupational and speech therapy

Requires prior authorization after 12 combined outpatient therapy visits.

Visits 1-12 no longer require authorization.

N/A

Existing

Durable medical equipment (DME)

Prior authorization is required for CPAP and BiPap devices, but will discontinue review of related supplies.

Existing

Existing

Leuprolide Depot (non-oncology/non-urology only)

Changed from “Eligard® to “Leuprolide Depot. Examples include Eligard®, Lupron Depot®.

Now excludes urology providers.

Existing

Existing

Self-injectables

Removed select medications (Aranesp®, Benlysta®, Cosentyx®, Granix®, Mircera®, Takhzyro) from the list, but still require PA under self-injectables.

For a list of self-injectables, go to the Provider Library at providerlibrary.healthnetcalifornia.com. Select Provider Manual > Benefits > Injectable > Self-Injectable Medications > Health Net Injectable Medications HCPCS/DOFR Crosswalk (PDF).

Existing

Existing

 

Deletions, effective January 1, 2021
RequirementCommentsAdult members ages 21 and overPediatric members under age 21

Bendeka®, Reclast®, Zemplar®, Zometa®

Listed under Outpatient Pharmaceuticals (Submitted under Medical Plan).

Existing

Existing

Commercial

Select lines of business have been abbreviated as follows: CommunityCare HMO is CC; CommunityCare HMO PPGs is CC PPGs; POS Tiers 1, 2 and 3 are POS T1, POS T2 and POS T3; out-of-state PPO is OOS PPO. Application of authorization requirement changes to EPO, PPO, OOS PPO, and Flex Net are based on group renewal date. Contact Health Net to confirm whether specific services require PA for group plans. “New” indicates new requirement, “Existing” indicates current requirement and “N/A” indicates not applicable.

Additions, effective January 1, 2021
                                                           Line of business
RequirementCommentsHMO, CC, HSP, POS T1CC PPGsPOS T2, POS T3EPO, PPO, OOS PPO, Flex Net

Biosimilars

Biosimilars are required to be used in lieu of branded drugs.

New

New

New

New

Continuous glucose monitoring

This is added under the durable medical equipment (DME) category.

New

New

New

N/A

  • Leuprolide Depot (non-oncology/non-urology only)
  • Ruconest®
  • Yervoy®

Listed under Outpatient Pharmaceuticals (Submitted under Medical Plan).

Leuprolide Depot examples include Eligard®, Lupron Depot®.

New

New

New

New

 

Changes, effective January 1, 2021
                                                                   Line of business
RequirementCommentsHMO, CC, HSP, POS T1CC PPGsPOS T2, POS T3EPO, PPO, OOS PPO, Flex Net

Durable medical equipment (DME)

Prior authorization is required for CPAP and BiPap devices, but will discontinue review of related supplies.

Existing

Existing

Existing

Existing

Occupational and speech therapy

Requires prior authorization after 12 combined outpatient therapy visits (occupational, speech and physical).

Visits 1-12 no longer require authorization.

Existing

Existing

Existing

Existing

Self-injectables

Removed select medications (Aranesp®, Benlysta®, Cosentyx®, Mircera®, Takhzyro) from the list, but still require PA under self-injectables.

For a list of self-injectables, refer to the DOFR crosswalk located in the Health Net Provider Library. Select Provider Manual > Benefits > Injectable > Self-Injectable Medications > Health Net Injectable Medications HCPCS/DOFR Crosswalk (PDF).

Existing

Existing

Existing

Existing

 

Deletions, effective January 1, 2021
                                            Line of business
RequirementCommentsHMO, CC, HSP, POS T1CC PPGsPOS T2, POS T3EPO, PPO, OOS PPO, Flex Net

Bendeka®

 

Existing

Existing

Existing

Existing

 

If you have questions regarding the information above, contact the applicable Health Net Provider Services Center at:

Line of Business

Telephone Number

Provider Portal

Email Address

EnhancedCare PPO (IFP)

1-844-463-8188


provider.healthnetcalifornia.com

 

provider_services@healthnet.com

EnhancedCare PPO (SBG)

1-844-463-8188


provider.healthnet.com

 

provider_services@healthnet.com

Health Net Employer Group HMO, POS, HSP, PPO, & EPO

1-800-641-7761


provider.healthnet.com

 

provider_services@healthnet.com

IFP (CommunityCare HMO, PPO, PureCare HSP, PureCare One EPO)

1-888-926-2164


provider.healthnetcalifornia.com

 

provider_services@healthnet.com

Medi-Cal

1-800-675-6110


provider.healthnet.com

 

N/A



Last Updated: 10/29/2020